dc.creatordel Portillo, Hernando
dc.creatorBadimón, Juan J.
dc.creatorCabrales Arevalo, Jaime Ramon
dc.creatorEcheverri Arcila, Darío
dc.date.accessioned2019-01-22T16:48:10Z
dc.date.available2019-01-22T16:48:10Z
dc.date.created2019-01-22T16:48:10Z
dc.date.issued2016
dc.identifierISSN 0120-5633
dc.identifierhttp://repository.urosario.edu.co/handle/10336/18904
dc.languagespa
dc.relationRevista Colombiana de Cardiologia, ISSN: 0120-5633, Vol. 23/No. 6 (2016) pp. 461-463
dc.relationhttps://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0120563316301875.pdf?locale=es_ES
dc.relation463
dc.relationNo. 6
dc.relation461
dc.relationRevista Colombiana de Cardiologia
dc.relationVol. 23
dc.rights
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectAcetylsalicylic Acid
dc.subjectAnticoagulant Agent
dc.subjectAntivitamin K
dc.subjectApixaban
dc.subjectClopidogrel
dc.subjectDabigatran
dc.subjectFibrinolytic Agent
dc.subjectGlycoprotein Iib Inhibitor
dc.subjectGlycoprotein Iiia Inhibitor
dc.subjectP2Y12 Receptor Inhibitor
dc.subjectProtein Inhibitor
dc.subjectRivaroxaban
dc.subjectTicagrelor
dc.subjectUnclassified Drug
dc.subjectWarfarin
dc.subjectAnticoagulation
dc.subjectAtrial Fibrillation
dc.subjectBleeding
dc.subjectCardiovascular Mortality
dc.subjectCerebrovascular Accident
dc.subjectClinical Research
dc.subjectColombia
dc.subjectCombination Chemotherapy
dc.subjectCoronary Artery Disease
dc.subjectDose Response
dc.subjectDrug Administration Route
dc.subjectDrug Efficacy
dc.subjectDrug Eluting Stent
dc.subjectDrug Indication
dc.subjectDrug Research
dc.subjectDrug Safety
dc.subjectEchocardiography
dc.subjectFollow Up
dc.subjectHeart Death
dc.subjectHeart Ejection Fraction
dc.subjectHeart Infarction
dc.subjectHeart Muscle Ischemia
dc.subjectHeart Ventricle Thrombosis
dc.subjectHuman
dc.subjectInternational Normalized Ratio
dc.subjectIntracoronary Drug Administration
dc.subjectMonotherapy
dc.subjectPercutaneous Coronary Intervention
dc.subjectPhase 2 Clinical Trial (Topic)
dc.subjectProphylaxis
dc.subjectRisk Assessment
dc.subjectSecondary Prevention
dc.subjectThrombectomy
dc.subjectTreatment Withdrawal
dc.titlePapel de los nuevos anticoagulantes orales en el tratamiento de la enfermedad coronaria
dc.typecontributionToPeriodical


Este ítem pertenece a la siguiente institución